Articles From: MACOM Announces Definitive Agreement to Sell Mindspeed CPE Communications Processor Business to Freescale Semiconductor to TetraLogic Agrees to Acquire Shape Pharmaceuticals, Inc.


LOWELL, Mass., April 7, 2014 (GLOBE NEWSWIRE) -- M/A-COM Technology Solutions Holdings, Inc. (Nasdaq:MTSI) (MACOM), a leading supplier of high performance RF, microwave, and millimeter wave products, today announced that its Mindspeed Technologies, Inc. subsidiary has entered into a definitive agreement to sell its CPE communication processor business to Freescale Semiconductor, including the Comcerto TM 100, 1000 and 2000 product families of multicore embedded processors.
Sign-up for MACOM Announces Definitive Agreement to Sell Mindspeed CPE Communications Processor Business to Freescale Semiconductor investment picks
ATLANTA, April 7, 2014 (GLOBE NEWSWIRE) -- MedAssets, Inc. (Nasdaq:MDAS) today announced that it plans to release its financial results for the first quarter ended March 31, 2014 after 4:00 p.m. ET on Wednesday, April 30, 2014.
Sign-up for MedAssets to Report First Quarter 2014 Financial Results on Wednesday, April 30th After 4:00 p.m. ET investment picks
HOUSTON, April 7, 2014 (GLOBE NEWSWIRE) -- Memorial Production Partners LP (Nasdaq:MEMP) announced today that John A.
Sign-up for Memorial Production Partners LP to Present at IPAA Oil & Gas Investment Symposium investment picks
SOUTH JORDAN, Utah, April 7, 2014 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI) , a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy, announced today that the Company will release its financial results for the first quarter ended March 31, 2014, after the close of the stock market on Thursday, April 24 th , 2014.
Sign-up for Merit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the First Quarter Ended March 31, 2014 investment picks
ATLANTA, April 7, 2014 (GLOBE NEWSWIRE) -- Mueller Water Products, Inc .
Sign-up for Mueller Water Products Announces Second Quarter Fiscal 2014 Earnings Release Date and Conference Call investment picks
NEW YORK, April 7, 2014 (GLOBE NEWSWIRE) -- The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) today reported monthly volumes for March 2014, and quarterly volumes and estimated revenue capture for the quarter ended March 31, 2014, on its investor relations website.
Sign-up for NASDAQ OMX March 2014 Volumes, 1Q14 Est. Revenue Capture investment picks
Leverages Ericsson's global scale and services leadership to offer broadcasters managed or hosted playout services that can be delivered worldwide Gives broadcasters access to a global connectivity network and innovative software-defined workflows Enables faster time to market, OTT and VOD distribution possibilities, and benefits such as increased flexibility, improved service delivery and reduced costs STOCKHOLM, Sweden, April 7, 2014 (GLOBE NEWSWIRE) -- Ericsson (NASDAQ: ERIC) is launching its Next Generation Playout solution at NAB Show 2014, the world's largest electronic media show.
Sign-up for Next Generation Playout provides global connectivity and unparalleled flexibility investment picks
GAITHERSBURG, Md., April 7, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) , a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced the appointment of Cynthia N.
Sign-up for Novavax Appoints Dr. Cindy Oliver as Senior Vice President, Process Development Operations investment picks
NEWTOWN, Pa., April 7, 2014 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX) , a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced the presentation of seven abstracts at the American Association for Cancer Research (AACR) Annual Meeting in San Diego, CA, being held April 5-9, 2014.
Sign-up for Onconova Development Programs Highlighted in Seven Presentations at AACR Annual Meeting investment picks
SOUTH SAN FRANCISCO, Calif., April 7, 2014 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN) , a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer, today announced results from three preclinical studies related to its ongoing research and development programs.
Sign-up for OXiGENE Announces Results of Promising Preclinical Studies at 2014 AACR Conference investment picks
GREELEY, Colo., April 7, 2014 (GLOBE NEWSWIRE) -- Pilgrim's Pride Corporation (Nasdaq:PPC) announced today that it will host its first quarter 2014 earnings conference call and webcast on Thursday, May 1, 2014 at 7:00 a.m. MDT (9:00 a.m. EDT). Prepared remarks regarding the company's financial and operational results will be followed by a question and answer period with Pilgrim's executive management team.
Sign-up for Pilgrim's Pride Corporation to Host 2014 First Quarter Earnings Call on May 1, 2014 investment picks
CHARLOTTE, N.C., April 7, 2014 (GLOBE NEWSWIRE) -- Polypore International, Inc. (NYSE:PPO) will release its first quarter 2014 financial results after U.S. markets close on Thursday, May 8, 2014.
Sign-up for Polypore Sets First Quarter 2014 Earnings Release and Conference Call Date investment picks
NEW YORK, April 7, 2014 (GLOBE NEWSWIRE) -- Pomerantz LLP has filed a class action lawsuit against The Medicines Company ("Medicines" or the "Company") (Nasdaq:MDCO) and certain of its officers.
Sign-up for Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in The Medicines Company of Class Action Lawsuit and Upcoming Deadline -- MDCO investment picks
NORFOLK, Va., April 7, 2014 (GLOBE NEWSWIRE) -- Portfolio Recovery Associates, Inc. (Nasdaq:PRAA) , a financial and business services company operating in the U.S., Canada and the U.K., today announced it had modified its Credit Agreement of December 19, 2012, as amended, increasing the company's domestic revolving credit commitments by $214.5 million, successfully securing from existing and new lenders the maximum amount of the facility's accordion loan feature.
Sign-up for PRA Expands Credit Facility to $842.5 Million Moving Closer to Acquisition of Aktiv Kapital investment picks
CHARLOTTE, N.C., April 7, 2014 (GLOBE NEWSWIRE) -- Premier, Inc. (Nasdaq:PINC) today announced it has acquired MEMdata, LLC, an equipment planning, sourcing and analytics business focused on capital equipment needs for existing medical facilities, as well as those under construction.
Sign-up for Premier, Inc. Acquires MEMdata investment picks
REDWOOD CITY, Calif., April 7, 2014 (GLOBE NEWSWIRE) -- Qualys, Inc. (Nasdaq:QLYS) , a pioneer and leading provider of cloud security and compliance solutions, today announced that the company will report its financial results for the first quarter of 2014 after the market closes on Monday, May 5, 2014.
Sign-up for Qualys to Report First Quarter 2014 Financial Results on May 5th investment picks
WOODLAND HILLS, Calif., April 7, 2014 (GLOBE NEWSWIRE) -- ReachLocal, Inc. (Nasdaq:RLOC) , a leader in powering local online marketing for small- to medium-sized businesses (SMBs), today announced it will report its first quarter 2014 financial results for the period ended March 31, 2014 following the close of market on Tuesday, May 6, 2014.
Sign-up for ReachLocal to Report First Quarter 2014 Results and Host Quarterly Conference Call on May 6 investment picks
The Company concluded a positive scientific advice meeting with the UK MHRA regarding RHB-102 and plans to submit, during the second half of the year, a European marketing application for the prevention of chemotherapy and radiotherapy-induced nausea and vomiting in cancer patients RHB-102 is a proprietary, once-daily, oral pill formulation of the anti-emetic oncology support drug ondansetron The Company commenced a comparative bioavailability study with RHB-102 to support its planned European marketing application, with study results expected by July 2014 In addition to the currently pursued indications, the MHRA provided guidance regarding a new undisclosed indication which may significantly expand RHB-102's potential market; A Phase III study for this indication is planned in the U.S. for later this year TEL-AVIV, Israel, April 7, 2014 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd.
Sign-up for RedHill Biopharma Announces Positive European Scientific Advice Meeting Regarding RHB-102 and Plans to Submit a European Marketing Application investment picks
COSTA MESA, Calif., April 7, 2014 (GLOBE NEWSWIRE) -- Pacific Mercantile Bancorp (Nasdaq:PMBC) and its wholly-owned subsidiary Pacific Mercantile Bank ("the Bank"), today announced that Robert J.
Sign-up for Robert J. Stevens Named EVP and Chief Credit Officer of Pacific Mercantile Bank investment picks
STEVENSON, Md., April 7, 2014 (GLOBE NEWSWIRE) -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Genworth Financial, Inc. ("Genworth" or the "Company") (NYSE:GNW) securities during the period between February 3, 2012 and April 17, 2012, inclusive (the "Class Period"). If you have suffered a loss from investment in Genworth securities purchased on or after February 3, 2012 and held through the revelation of negative information on April 17, 2012, as described below, and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, without cost or financial obligation, click here: http://www.browerpiven.com/securitiesfraudcases.html .
Sign-up for SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Genworth Financial, Inc. to Contact Brower Piven Before the June 3, 2014 Lead Plaintiff Deadline -- GNW investment picks
NEW YORK, April 7, 2014 (GLOBE NEWSWIRE) -- Pomerantz LLP has filed a class action lawsuit against Coty, Inc. ("Coty" or the "Company") (NYSE:COTY) and certain of its officers.
Sign-up for SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholder With Losses on Their Investment in Coty, Inc. of Class Action Lawsuit and Upcoming Deadline -- COTY investment picks
NEW YORK, April 7, 2014 (GLOBE NEWSWIRE) -- Pomerantz LLP has filed a class action lawsuit against Montage Technology Group Ltd.
Sign-up for SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Montage Technology Group Ltd. of Class Action Lawsuit and Upcoming Deadline -- MONT investment picks
TAIPEI, Taiwan, April 7, 2014 (GLOBE NEWSWIRE) -- Silicon Motion Technology Corporation (Nasdaq:SIMO) ("Silicon Motion" or the "Company"), a global leader in designing and marketing NAND flash controllers for solid state storage devices and specialty RF IC solutions for mobile devices, announces that based upon its preliminary financial results, sequential revenue growth for the first quarter is expected to be near the high-end of the original guidance range that the company issued on January 28, 2014, of flat to down 10% sequentially.
Sign-up for Silicon Motion Announces Preliminary First Quarter 2014 Revenue and Earnings Conference Call Details investment picks
WHITE PLAINS, N.Y., April 7, 2014 (GLOBE NEWSWIRE) -- SPAR Group, Inc. (Nasdaq:SGRP) ("we", the "Company" or "SPAR Group"), a leading supplier of retail merchandising and other marketing services throughout the United States and internationally, today announced the appointment of Panos Mastrogiannis as Chief Information Officer and Executive Officer.
Sign-up for SPAR Group Appoints Chief Information Officer and Provides Shareholders With an Update on Its Technological Advances investment picks
COLORADO SPRINGS, Colo., April 7, 2014 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced preliminary results for the three months ended March 31, 2014.
Sign-up for Spectranetics Announces Preliminary Results for First Quarter 2014 and Updates 2014 Guidance investment picks
NEW YORK, April 7, 2014 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML) announced today that Ivan Bergstein, M.D., Stemline's CEO, will present at the 13th Annual Needham Healthcare Conference on Tuesday, April 8, 2014 at 12:10 PM ET.
Sign-up for Stemline Therapeutics to Present at the 13th Annual Needham Healthcare Conference investment picks
GENEVA, April 7, 2014 (GLOBE NEWSWIRE) -- STMicroelectronics (NYSE:STM) , a global semiconductor leader serving customers across the spectrum of electronics applications, announced that it will release first quarter 2014 earnings after the close of trading on the New York Stock Exchange on Monday, April 28, 2014.
Sign-up for STMicroelectronics Announces Timing for 1st Quarter 2014 Earnings Release and Conference Call investment picks
SUGAR LAND, Texas, April 7, 2014 (GLOBE NEWSWIRE) -- Team, Inc. (NYSE:TISI) today announced financial results for its fiscal year 2014 third quarter ending February 28, 2014.
Sign-up for Team, Inc. Reports Third Quarter Results investment picks
CLEARWATER, Fla., April 7, 2014 (GLOBE NEWSWIRE) -- Tech Data Corporation (Nasdaq:TECD) today announced that it plans to host an investor conference call and webcast on April 9, 2014 at 9:00 a.m. ET to discuss results for its fourth quarter and fiscal year ended January 31, 2014.
Sign-up for Tech Data Corporation to Host Conference Call to Discuss Fourth-Quarter and Fiscal Year 2014 Results investment picks
SHAPE, a novel, tissue-targeted topical HDAC inhibitor, is expected to enter Phase 2 trials for early-stage CTCL Encouraging responses seen in a randomized Phase 1 trial after only 28 days of use, with no significant safety events SHAPE is designed to avoid systemic absorption and related HDACi toxicities Adds second clinical-stage oncology compound to the TetraLogic portfolio Conference call at 8:00 a.m., tomorrow, April 8, 2014 MALVERN, Pa., April 7, 2014 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG) announced today that it has executed a definitive agreement to acquire by merger 100% of Shape Pharmaceuticals, a privately-held biotechnology company developing suberohydroxamic acid phenyl ester (SHAPE), a novel, tissue-targeted HDAC inhibitor in a topical gel formulation to treat stage IA-IIA Cutaneous T-Cell Lymphoma (CTCL), adding a second clinical-stage oncology compound to the TetraLogic portfolio.
Sign-up for TetraLogic Agrees to Acquire Shape Pharmaceuticals, Inc. investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: MACOM Announces Definitive Agreement to Sell Mindspeed CPE Communications Processor Business to Freescale Semiconductor to TetraLogic Agrees to Acquire Shape Pharmaceuticals, Inc.
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry